1
|
Ramírez-Palacios P, Chen A, Flores YN, Crespi CM, Lazcano-Ponce E, Alvarez-Escobedo D, Torres-Ibarra L, Rivera-Paredez B, León-Maldonado L, Hernández-López R, Mendiola-Pastrana IR, Méndez-Hernández P, Cuzick J, Carmona E, Figueroa H, Montiel-Cordero F, Meneses-León J, Rao J, Salmerón J. Benefit of double-reading cytology smears as a triage strategy among high-risk human papillomavirus-positive women in Mexico. Cancer Cytopathol 2020; 128:715-724. [PMID: 32520446 DOI: 10.1002/cncy.22303] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Revised: 05/01/2020] [Accepted: 05/11/2020] [Indexed: 01/08/2023]
Abstract
BACKGROUND The goal of this study was to determine whether the detection of histologically confirmed cases of cervical high-grade squamous intraepithelial lesions or worse (HSIL+) can be increased by having each liquid-based cytology (LBC) slide read by 2 cytotechnologists as part of routine screening. METHODS Over 36,212 women aged 30 to 64 years participated in the Forwarding Research for Improved Detection and Access for Cervical Cancer Screening and Triage (FRIDA) Study in Mexico between 2013 and 2016. For each participant, 2 cervical samples were collected at the same clinic visit, one to test for high-risk human papillomavirus (hrHPV) and the other for LBC, which was used to triage those with a hrHPV positive result. LBC slides were evaluated by 7 cytotechnologists, with each slide read independently by 2 blinded cytotechnologists. All women with atypical cells of undetermined significance or a worse result were referred to colposcopy for further evaluation and diagnosis. Three pathologists evaluated the biopsy specimens to confirm the final HSIL+ diagnosis. The HSIL+ detection rates for the single versus double reading were estimated and compared. RESULTS A total of 3,914 women with a positive hrHPV result were triaged with LBC. The first and second cytology readings resulted in 43 HSIL+ cases detected; the double-reading strategy detected 9 additional HSIL+ cases, resulting in a total of 52 HSIL+ cases. The HSIL+ detection rate increased from 10.99/1000 with a single reading to 13.29/1000 with the double-reading strategy (P = .004). CONCLUSION A 20.9% increase in HSIL+ cases detected was achieved with a double reading of the LBC slides in this sample of hrHPV-positive women.
Collapse
Affiliation(s)
- Paula Ramírez-Palacios
- Unidad de Investigación Epidemiológica y en Servicios de Salud, Delegación Morelos, Instituto Mexicano del Seguro Social, Cuernavaca, Mexico
| | - Aiyu Chen
- Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, California
| | - Yvonne N Flores
- Unidad de Investigación Epidemiológica y en Servicios de Salud, Delegación Morelos, Instituto Mexicano del Seguro Social, Cuernavaca, Mexico
- Department of Health Policy and Management and Kaiser Permanente Center for Health Equity, Fielding School of Public Health, University of California, Los Angeles, California
- UCLA Cancer Prevention and Control Research Center, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California
| | - Catherine M Crespi
- Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, California
- UCLA Cancer Prevention and Control Research Center, Fielding School of Public Health and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California
| | - Eduardo Lazcano-Ponce
- Centro de Investigación en Salud Poblacional. Instituto Nacional de Salud Pública, Cuernavaca, Mexico
| | - Daniel Alvarez-Escobedo
- Unidad de Medicina Familiar, Hospital General Regional No. 1, Instituto Mexicano del Seguro Social, Cuernavaca, Mexico
| | - Leticia Torres-Ibarra
- Centro de Investigación en Salud Poblacional. Instituto Nacional de Salud Pública, Cuernavaca, Mexico
| | - Berenice Rivera-Paredez
- Centro de Investigación en Salud Poblacional. Instituto Nacional de Salud Pública, Cuernavaca, Mexico
- Centro de Investigación en Políticas, Población y Salud, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | | | - Rubí Hernández-López
- Centro de Investigación en Salud Poblacional. Instituto Nacional de Salud Pública, Cuernavaca, Mexico
- Centro de Investigación en Políticas, Población y Salud, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - Indira R Mendiola-Pastrana
- Centro de Investigación en Salud Poblacional. Instituto Nacional de Salud Pública, Cuernavaca, Mexico
- Centro de Investigación en Políticas, Población y Salud, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - Pablo Méndez-Hernández
- Departamento de Calidad y Educación en Salud, Secretaria de Salud Tlaxcala, Santa Ana Chiautempan, Mexico
- Facultad de Ciencias de la Salud, Universidad Autónoma de Tlaxcala, Zacatelco, Mexico
| | - Jack Cuzick
- Wolfson Institute of Preventive Medicine, Centre for Cancer Prevention, Queen Mary University of London, London, United Kingdom
| | | | - Héctor Figueroa
- Laboratorio de Citología, Laboratorio Estatal de Salud Pública, Tlaxcala, México
| | | | - Joacim Meneses-León
- Centro de Investigación en Salud Poblacional. Instituto Nacional de Salud Pública, Cuernavaca, Mexico
- Centro de Investigación en Políticas, Población y Salud, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - Jianyu Rao
- Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California
| | - Jorge Salmerón
- Centro de Investigación en Salud Poblacional. Instituto Nacional de Salud Pública, Cuernavaca, Mexico
- Centro de Investigación en Políticas, Población y Salud, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
| |
Collapse
|
2
|
Placidi A, Giorgi Rossi P. The impact of blind peer review (team reading) of equivocal/abnormal Papanicolaou smears on inter-reader agreement. Cytopathology 2018; 30:105-108. [PMID: 30276905 DOI: 10.1111/cyt.12637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2017] [Revised: 09/03/2018] [Indexed: 11/29/2022]
Abstract
OBJECTIVE Peer review of equivocal/abnormal Papanicolaou smears is a standard internal quality assurance measure in cervical cancer screening laboratories. In 2014, we introduced a new method for peer review involving blinding the identity of the first reader. We present the comparison of different measures of inter-reader agreement in 2013 and 2014 in order to measure the impact of blind peer review on possible cognitive biases in reading. METHODS All suspect slides are proposed for peer review; a single reader's peer reviews are registered independently, with discordant cases discussed for consensus diagnosis. Since 2014, the first reader's name has been blinded to peers. We computed how frequently the initial diagnosis was changed, and how frequently a single reader influenced the final diagnosis when the initial one was changed. We compared κ of the first reader and that of other readers with final diagnosis. Data from 2013 were compared to those of 2014. RESULTS The final diagnosis changed in 22.9% of cases (range 16.8%-34.4%) in 2013 and in 26.8% (range 13.9%-35.6%) in 2014 (P = .2). Individual peer diagnoses agreed with final diagnosis in 52.3% (range 41.9%-66.3%) in 2013 and in 50.2% (range 36.0%-65.8%) in 2014 (P = .55). The cytologist having the highest proportion of confirmed diagnoses was also the most influential on final diagnosis, both in 2013 and in 2014. Agreement between first reader and final diagnosis was higher than that of each reader in 2013 and in 2014. CONCLUSIONS Blinding the identity of the first reader had little or no impact on inter-reader agreement measures in our laboratory.
Collapse
Affiliation(s)
- Antonio Placidi
- U.O.C. Oncologic Screening, Local Health Unit Roma 2 (Former Roma C), Roma, Italy
| | - Paolo Giorgi Rossi
- Epidemiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy
| |
Collapse
|
3
|
Tobias AHG, Vitalino AC, Rezende MT, Oliveira RRR, Coura-Vital W, Amaral RG, Carneiro CM. Performance of rapid prescreening and 100% rapid review as internal quality control methods for cervical cytopathology. Cytopathology 2018; 29:428-435. [PMID: 29904955 DOI: 10.1111/cyt.12599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/14/2018] [Indexed: 11/29/2022]
Abstract
BACKGROUND An objective of quality control for cervical cytopathology is reducing high rates of false-negative results of laboratory tests. Therefore, methods to review smears such as rapid prescreening and 100% rapid review, which have shown better performance detecting false-negative results, have been widely used. The performance of rapid prescreening and the performance of 100% rapid review as internal quality control methods for cervical cytology examinations were evaluated. METHODS For 24 months, 9318 conventional cervical cytology smears underwent rapid prescreening and routine screening. The 100% rapid review method was performed for 8244 smears classified as negative during routine screening. Any discordant results underwent detailed review to define the final diagnosis. This was considered the gold standard for evaluating the performance of rapid prescreening and 100% rapid review. RESULTS Routine screening showed increases of 13.3% and 11.5% in the detection of abnormal smears with rapid prescreening and 100% rapid review, respectively. The relative percentage variation showed a 38.1% increase in the diagnosis of atypical squamous cells of undetermined significance with routine screening and rapid prescreening and a 12.5% increase in the diagnosis of atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion with both rapid prescreening and 100% rapid review. Sensitivity rates of rapid prescreening and routine screening were 48.2% and 83.2%, respectively. Sensitivity rates of rapid prescreening and 100% rapid review were 65.7% and 57.8%, respectively, for detecting false-negative results. CONCLUSIONS Inclusion of rapid prescreening and/or 100% rapid review improved the diagnostic sensitivity of the cervical cytology examination and reduced false-negative results of routine screening and can provide good quality control.
Collapse
Affiliation(s)
- A H G Tobias
- Post-Graduate Program in Pharmaceutical Sciences, School of Pharmacy, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil.,Clinical Cytology Section, Laboratory of Clinical Analysis, School of Pharmacy, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil
| | - A C Vitalino
- Post-Graduate Program in Pharmaceutical Sciences, School of Pharmacy, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil
| | - M T Rezende
- Post-Graduate Program in Pharmaceutical Sciences, School of Pharmacy, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil.,Clinical Cytology Section, Laboratory of Clinical Analysis, School of Pharmacy, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil
| | - R R R Oliveira
- Clinical Cytology Section, Laboratory of Clinical Analysis, School of Pharmacy, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil
| | - W Coura-Vital
- Department of Clinical Analysis, School of Pharmacy, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil
| | - R G Amaral
- School of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil
| | - C M Carneiro
- Post-Graduate Program in Pharmaceutical Sciences, School of Pharmacy, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil.,Clinical Cytology Section, Laboratory of Clinical Analysis, School of Pharmacy, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil.,Department of Clinical Analysis, School of Pharmacy, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil
| |
Collapse
|
4
|
Dahabreh IJ, Trikalinos TA, Lau J, Schmid CH. Univariate and bivariate likelihood-based meta-analysis methods performed comparably when marginal sensitivity and specificity were the targets of inference. J Clin Epidemiol 2017; 83:8-17. [PMID: 28063915 DOI: 10.1016/j.jclinepi.2016.12.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2012] [Revised: 10/04/2016] [Accepted: 12/01/2016] [Indexed: 11/16/2022]
Abstract
OBJECTIVES To compare statistical methods for meta-analysis of sensitivity and specificity of medical tests (e.g., diagnostic or screening tests). STUDY DESIGN AND SETTING We constructed a database of PubMed-indexed meta-analyses of test performance from which 2 × 2 tables for each included study could be extracted. We reanalyzed the data using univariate and bivariate random effects models fit with inverse variance and maximum likelihood methods. Analyses were performed using both normal and binomial likelihoods to describe within-study variability. The bivariate model using the binomial likelihood was also fit using a fully Bayesian approach. RESULTS We use two worked examples-thoracic computerized tomography to detect aortic injury and rapid prescreening of Papanicolaou smears to detect cytological abnormalities-to highlight that different meta-analysis approaches can produce different results. We also present results from reanalysis of 308 meta-analyses of sensitivity and specificity. Models using the normal approximation produced sensitivity and specificity estimates closer to 50% and smaller standard errors compared to models using the binomial likelihood; absolute differences of 5% or greater were observed in 12% and 5% of meta-analyses for sensitivity and specificity, respectively. Results from univariate and bivariate random effects models were similar, regardless of estimation method. Maximum likelihood and Bayesian methods produced almost identical summary estimates under the bivariate model; however, Bayesian analyses indicated greater uncertainty around those estimates. Bivariate models produced imprecise estimates of the between-study correlation of sensitivity and specificity. Differences between methods were larger with increasing proportion of studies that were small or required a continuity correction. CONCLUSION The binomial likelihood should be used to model within-study variability. Univariate and bivariate models give similar estimates of the marginal distributions for sensitivity and specificity. Bayesian methods fully quantify uncertainty and their ability to incorporate external evidence may be useful for imprecisely estimated parameters.
Collapse
Affiliation(s)
- Issa J Dahabreh
- Center for Evidence Synthesis in Health, School of Public Health, Brown University, 121 South Main St, Box G-S121-8, Providence, RI 02912, USA; Department of Health Services Policy & Practice, School of Public Health, Brown University, 121 South Main St, Box G-S121-8, Providence, RI 02912, USA
| | - Thomas A Trikalinos
- Center for Evidence Synthesis in Health, School of Public Health, Brown University, 121 South Main St, Box G-S121-8, Providence, RI 02912, USA; Department of Health Services Policy & Practice, School of Public Health, Brown University, 121 South Main St, Box G-S121-8, Providence, RI 02912, USA
| | - Joseph Lau
- Center for Evidence Synthesis in Health, School of Public Health, Brown University, 121 South Main St, Box G-S121-8, Providence, RI 02912, USA; Department of Health Services Policy & Practice, School of Public Health, Brown University, 121 South Main St, Box G-S121-8, Providence, RI 02912, USA
| | - Christopher H Schmid
- Center for Evidence Synthesis in Health, School of Public Health, Brown University, 121 South Main St, Box G-S121-8, Providence, RI 02912, USA; Department of Biostatistics, School of Public Health, Brown University, Providence, 121 South Main St, Box G-S121-8, Providence, RI 02912, USA.
| |
Collapse
|
5
|
Feoli F, Renard C, Abouyahia M, De Wind R, Larsimont D, Arbyn M. Retrospective Rescreening of Negative Cervical Cytology Samples Preceding Histologically Proven CIN2-3 and Squamous Cell Carcinoma: An Educational Opportunity to Understand and Prevent Laboratory Errors. Acta Cytol 2015; 59:265-72. [PMID: 26279075 DOI: 10.1159/000430882] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2015] [Accepted: 04/22/2015] [Indexed: 12/17/2022]
Abstract
OBJECTIVES We aimed to analyze the false-negative (FN) liquid-based cytology diagnoses from the 5 years preceding all the 2013 histologically proven cervical intraepithelial neoplasia (CIN)2-3 and squamous cell carcinoma (SCC) and to propose corrective actions. STUDY DESIGN This was a retrospective, blinded rescreening ('5-year look-back') of liquid-based cytology samples with negative categorizations, which occurred before histologically proven CIN2-3 and SCC. RESULTS The FN rate was 7.8% (21/256 samples preceding CIN2-3 and 0/13 samples preceding SCC). Slides confirmed as 'negative', 'interpretation error' and 'screening error', respectively, were 3.3% (9/269), 2.6% (7/269) and 1.9% (5/269). In 9/12 cases, error was associated with small atypical cells. In 7/12 cases, these diagnostic cells were less than 5/10 HPF. Inflammation and prominent reactive changes were present in 5/12 cases. Five patients had a positive clinical history. In 2 cases, there were multiple-cell-layer artifacts. Dense groups of small blue atypical cells were missed in 2 other cases. Dotting was imprecise in 6/7 samples. CONCLUSION Considering the above results, we specifically reoriented our continuous education activities, focusing rapid rescreening on scanty, isolated, small, atypical cells and dense cell groups. Prior to final diagnosis, pathologists should systematically review the entire surface of the dotted slides, with special attention being devoted to slides with multiple cell layers and tridimensional groups.
Collapse
Affiliation(s)
- Francesco Feoli
- Anatomic Pathology Laboratory, Institut Bordet, Universitx00E9; Libre de Bruxelles, Brussels, Belgium
| | | | | | | | | | | |
Collapse
|
6
|
Heard T, Chandra A, Culora G, Gupta SS, Herbert A, Morgan M. Use of the ThinPrep Imaging System for internal quality control of cervical cytology. Cytopathology 2012; 24:246-53. [DOI: 10.1111/cyt.12010] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
7
|
Frable WJ, Pedigo MA, Powers CN, Yarrell C, Ortiz B, Clark ME, Ebron T. Rapid prescreen of cervical liquid-based cytology preparations: results of a study in an academic medical center. Diagn Cytopathol 2012; 40:691-7. [PMID: 22807384 DOI: 10.1002/dc.21598] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2010] [Accepted: 10/15/2010] [Indexed: 11/08/2022]
Abstract
A rapid prescreening or rapid rescreening method for quality assurance in cervical cytology has been used in Europe and in Canada but has not been accepted in the United States. The rapid prescreen method was tested in a cytology laboratory that serves an academic medical center with a high-risk population for cervical cancer. For a period of 3 months, a tray of 20 sequentially numbered Surepath™ liquid-based preparations, randomly selected from the cervical cytology daily workload, were each prescreened in a random fashion for 1 minute. Experienced cytotechnologists performed the rapid prescreen. Results were recorded as negative, further review needed, or epithelial cell abnormality, category specified. The 20 cervical cytology preparations were then replaced in their same position in the daily workload for routine screening performed by another cytotechnologist. Final interpretation was by a cytopathologist as requested or required by Clinical Laboratory Improvement Amendments of 1988. The rapid prescreen data was tabulated and compared with data for a similar time period using the laboratory's normal quality assurance program. Seven hundred and twelve cases underwent rapid prescreen. Six hundred and forty-two were interpreted as negative. Twenty-six cases were interpreted as low-grade squamous intraepithelial lesion (LGSIL) or higher. Forty-four cases were classified as needing further review. For the 642 negative cases by rapid prescreening, routine screening reported 537 as negative and 105 as either abnormal or needed cytopathologist review. The error rate for the rapid prescreen is 50 of 712 (7.0%); for LGSIL and above 19 of 712 (2.6%). Of the 105 abnormal cases or those submitted for cytopathologist review, 31 were interpreted as atypical squamous cells of undermined significance (ASCUS), 41 cases as reactive/repair, 17 as LGSIL, 4 as unsatisfactory, 1 as atypical squamous cells, cannot rule out high-grade squamous intraepithelial lesion (ASC-H), 8 as the presence of endometrial cells in a women aged >40, 1 as malignant melanoma, and 2 as within normal limits with the presence of Actinomyces. The laboratory's routine quality assurance program selects cases, 10% of initially interpreted negative cases plus any gynecologic cytology on patients with a prior abnormal cervical cytology, or history of cervical epithelial cell abnormality. This quality assurance program averages 29% of cases, 4,045 of a total of 13,767, in 2008. Thirty-seven (0.9%) cases were detected in this rescreen (ASCUS, 16 cases; LGSIL, 13 cases; 1 high-grade squamous intraepithelial lesion; 4 ASC-H; and 3 atypical glandular cells of undetermined significance). Eliminating ASCUS cases, eight significant cases were detected, with an error rate of 0.2%. In this cytology laboratory, the rapid prescreen did not prove as reliable as routine quality assurance program for cervical cytology cases.
Collapse
Affiliation(s)
- William J Frable
- Department of Pathology, Virginia Commonwealth University Medical Center, Richmond, VA, USA.
| | | | | | | | | | | | | |
Collapse
|
8
|
Currens HS, Nejkauf K, Wagner L, Raab SS. Effectiveness of rapid prescreening and 10% rescreening in liquid-based Papanicolaou testing. Am J Clin Pathol 2012; 137:150-5. [PMID: 22180489 DOI: 10.1309/ajcp6lw4sybtisow] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022] Open
Abstract
Although rapid prescreening (RPS) has been shown to be an effective quality control procedure for detecting false-negative conventional Papanicolaou (Pap) tests, RPS has not been widely implemented in the United States. In our laboratory, cytotechnologists performed RPS in 3,567 liquid-based Pap tests: 1,911 SurePath (BD Diagnostics-TriPath, Burlington, NC) preparations that were manually screened and 1,656 ThinPrep Pap tests (Hologic, Bedford, MA) that were imaged using the ThinPrep Imaging System (Hologic). We compared the sensitivity of RPS, 10% rescreening (R-10%), and routine screening (RS). In contrast with previously published findings, we found that RS + RPS did not improve screening sensitivity compared with RS + R-10%. These results support the following hypotheses: (1) Higher baseline RS sensitivity as a result of Pap test diagnoses standardization implemented for quality improvement purposes decreases the performance impact of RPS. (2) R-10% and RPS quality assurance methods detect diagnostic failures caused by different types of cognitive errors.
Collapse
|
9
|
Auger M. Rapid prescreening in gynecologic cytology: A more efficient quality assurance method. Cancer Cytopathol 2011; 119:357-60. [PMID: 21954172 DOI: 10.1002/cncy.20189] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2011] [Accepted: 07/29/2011] [Indexed: 11/11/2022]
Affiliation(s)
- Manon Auger
- Department of Pathology, McGill University Health Center and McGill University, Montreal, Quebec, Canada.
| |
Collapse
|
10
|
Tavares SBN, Alves de Sousa NL, Manrique EJC, Pinheiro de Albuquerque ZB, Zeferino LC, Amaral RG. Improvement in the routine screening of cervical smears. Cancer Cytopathol 2011; 119:367-76. [DOI: 10.1002/cncy.20190] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2011] [Accepted: 05/17/2011] [Indexed: 11/06/2022]
|
11
|
Wilgenbusch H, Mueller G, Neal M, Renshaw AA. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device. Diagn Cytopathol 2010; 39:818-21. [DOI: 10.1002/dc.21469] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2010] [Accepted: 05/05/2010] [Indexed: 11/12/2022]
|
12
|
Brimo F, Renshaw AA, Deschenes M, Charbonneau M, Auger M. Improvement in the routine screening performance of cytotechnologists over time. Cancer Cytopathol 2009; 117:311-7. [DOI: 10.1002/cncy.20042] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
13
|
Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J. Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med 2009; 13:648-59. [PMID: 19166485 PMCID: PMC3822872 DOI: 10.1111/j.1582-4934.2008.00631.x] [Citation(s) in RCA: 85] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Consistent evidence underlines the utility of human papillomavirus (HPV) DNA testing in the management of women with equivocal cervical cytological abnormalities, but not in case of low-grade lesions. We performed a meta-analysis including studies where the high-risk probe of the Hybrid Capture-II is used to triage these two cytological categories. The triage test-positivity rate reflects the colposcopy referral workload.Data were pooled on the HPV test positivity rate in women with atypical squamous cells of undetermined significance (ASCUS/ASC-US) or low-grade squamous intraepithelial lesions (LSIL), derived from different cytological classification systems. The meta-analysis was restricted to studies, published between 1991 and 2007. A random-effect model was applied for meta-analytical pooling and the influence of covariates on the HPV positivity rate was analyzed by meta-regression. The variation by age was assessed within individual studies since age strata were not defined uniformly. On an average, 43% (95% CI: 40–46%) of women with ASCUS/ASC-US were high-risk HPV positive (range 23–74%). In women with LSIL, the pooled positivity rate was 76% (95% CI: 71–81%; range 55–89%). In spite of considerable inter-study heterogeneity, the difference in HPV positivity between the two triage groups was large and highly significant: 32% (95% CI: 27–38%). HPV rates dropped tremendously as age and cutoffs of test positivity increased. Other factors (cytological classification system, country, continent, collection method and year of publication) had no statistically significant impact, except in LSIL triage where HPV positivity was significantly lower in European compared to American studies. Women with LSIL, especially younger women, have high HPV positivity rates suggesting limited utility of reflex HPV triaging these cases. Research is needed to identify more specific methods to triage women with low-grade squamous cervical lesions.
Collapse
Affiliation(s)
- Marc Arbyn
- Scientific Institute of Public Health, Brussels, Belgium.
| | | | | | | | | | | |
Collapse
|
14
|
do Nascimento Tavares SB, de Sousa NLA, Manrique EJC, de Albuquerque ZBP, Zeferino LC, Amaral RG. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme. Cytopathology 2008; 19:254-9. [DOI: 10.1111/j.1365-2303.2008.00562.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
15
|
Abstract
PURPOSE OF REVIEW The objective of cervical cancer screening is to prevent the occurrence of and death from cervical cancer by detecting and treating high-grade squamous intraepithelial lesions. A significant decline in occurrence and mortality from cervical cancer in developed countries has been associated with the application of organized cervical screening programs. The use of the available local health methods in cervical cancer screening can be adjusted in different countries. This review discusses the recent results in traditional and alternative cervical cancer screening. RECENT FINDINGS The current recommendations of both the American Cancer Society and the American College of Obstetricians and Gynecologists concerning clinical practice guidelines for cervical cancer screening are commented upon. New methods and new technology for cervical cancer screening are described. Attributable failure factors in the screening process, particularly in the coverage, are analyzed. A critical assessment of the suitability of local cervical cancer screening resources is discussed. SUMMARY Screening is clearly a complex multifactorial process, not a test. Nowadays, with the human papillomavirus vaccine on the horizon, screening is the best strategy for cervical cancer control. Good screening programs, with high coverage, quality control and follow-up included, are the basis of obtaining better results. The Papanicolaou test and its variants are the best methods of cervical cancer screening in high-resource settings. Alternative visual inspection using cervical dyes could be the most useful method in low-resource settings. The challenge for the future may be less of a technical nature and more dependent on local finances and screening policies.
Collapse
Affiliation(s)
- Victor M Valdespino
- Gynecologic Department, UMAE de Oncología del CMN SXXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
| | | |
Collapse
|
16
|
Depuydt CE, Arbyn M, Benoy IH, Vandepitte J, Vereecken AJ, Bogers JJ. Quality control for normal liquid-based cytology: rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection? J Cell Mol Med 2008; 13:4051-60. [PMID: 18544049 PMCID: PMC4516552 DOI: 10.1111/j.1582-4934.2008.00379.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Abstract
The objective of this prospective study was to compare the number of CIN2+cases detected in negative cytology by different quality control (QC) methods. Full rescreening, high-risk (HR) human papillomavirus (HPV)-targeted reviewing and HR HPV detection were compared. Randomly selected negative cytology detected by BD FocalPoint™ (NFR), by guided screening of the prescreened which needed further review (GS) and by manual screening (MS) was used. A 3-year follow-up period was available. Full rescreening of cytology only detected 23.5% of CIN2+ cases, whereas the cytological rescreening of oncogenic positive slides (high-risk HPV-targeted reviewing) detected 7 of 17 CIN2+ cases (41.2%). Quantitative real-time PCR for 15 oncogenic HPV types detected all CIN2+ cases. Relative sensitivity to detect histological CIN2+ was 0.24 for full rescreening, 0.41 for HR-targeted reviewing and 1.00 for HR HPV detection. In more than half of the reviewed negative cytological preparations associated with histological CIN2+cases no morphologically abnormal cells were detected despite a positive HPV test. The visual cut-off for the detection of abnormal cytology was established at 6.5 HR HPV copies/cell. High-risk HPV detection has a higher yield for detection of CIN2+ cases as compared to manual screening followed by 5% full review, or compared to targeted reviewing of smears positive for oncogenic HPV types, and show diagnostic properties that support its use as a QC procedure in cytologic laboratories.
Collapse
Affiliation(s)
- Christophe E Depuydt
- Laboratory for Clinical Pathology, Labo Lokeren, campus RIATOL, Amerikalei, Antwerp, Belgium.
| | | | | | | | | | | |
Collapse
|
17
|
Tavares SBN, Alves de Sousa NL, Manrique EJC, Pinheiro de Albuquerque ZB, Zeferino LC, Amaral RG. Comparison of the performance of rapid prescreening, 10% random review, and clinical risk criteria as methods of internal quality control in cervical cytopathology. Cancer 2008; 114:165-70. [DOI: 10.1002/cncr.23509] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
18
|
|
19
|
Bofin AM, Nygård JF, Skare GB, Dybdahl BM, Westerhagen U, Sauer T. Papanicolaou smear history in women with low-grade cytology before cervical cancer diagnosis. Cancer 2007; 111:210-6. [PMID: 17567833 DOI: 10.1002/cncr.22865] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND The purpose of the current study was to examine the screening histories of women diagnosed with invasive cervical cancer (ICC) in 2000 who had previous Papanicolaou (Pap) smears deemed to be unsatisfactory or with low-grade findings that did not lead to biopsy. METHODS A total of 252 Pap smears from 47 women taken between 1992 and 2000 were included in the study; 247 smears were reexamined at the laboratory of origin before the study and all 252 were then reexamined independently by 2 experienced cytotechnicians and 2 cytopathologists. RESULTS Of the 47 cases of ICC, 35 were squamous cell carcinoma, 10 were adenocarcinoma, and 2 were other types. On reexamination at the laboratory of origin, 24 cases were upgraded and in the study group 27 cases were upgraded to diagnoses requiring biopsy. On reexamination at the laboratory of origin, it was found that the first high-grade squamous intraepithelial lesion (HSIL) could have been diagnosed on average 4.2 years earlier than it was originally (95% confidence interval [95% CI], 3.3-5.1 years). On reexamination by the study group the first diagnosis of HSIL was made in smears dating from 5.4 years before the diagnosis of ICC (95% CI, 4.5-6.2 years). CONCLUSIONS The study confirms that unsatisfactory and low-grade Pap smears imply a risk of developing high-grade lesions at a later date and shows that in a screening program a subgroup of smears may be diagnosed as unsatisfactory or low grade despite the presence of high-grade findings that are detectable on reexamination.
Collapse
Affiliation(s)
- Anna M Bofin
- Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
| | | | | | | | | | | |
Collapse
|
20
|
Wiener HG, Klinkhamer P, Schenck U, Arbyn M, Bulten J, Bergeron C, Herbert A. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories. Cytopathology 2007; 18:67-78. [PMID: 17397490 DOI: 10.1111/j.1365-2303.2007.00451.x] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The quality of a cervical cytology laboratory depends on adequate handling and staining of the samples, screening and interpretation of the slides and reporting of the results. These guidelines give an overview of procedures recommended in Europe to manage the balance between best patient care possible, laboratory quality assurance and cost effectiveness and will be published as a chapter 4 in the European Guidelines for Quality Assurance in Cervical Cancer Screening. The laboratory guidelines include protocols for personnel and organisation, material requirements, handling and analysing cervical samples, recording of results, quality management and communication. The section on quality management is comprehensive and includes protocols for all aspects of internal and external quality assurance. The guidelines are extensively referenced and as far as possible the recommendations are evidence-based.
Collapse
Affiliation(s)
- H G Wiener
- Institute of Clinical Pathology, University Vienna, Austria.
| | | | | | | | | | | | | |
Collapse
|
21
|
Pajtler M, Audy-Jurković S, Skopljanac-Macina L, Antulov J, Barisić A, Milicić-Juhas V. Rapid cervicovaginal smear screening: method of quality control and assessing individual cytotechnologist performance. Cytopathology 2006; 17:121-6. [PMID: 16719854 DOI: 10.1111/j.1365-2303.2006.00367.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
AIM To validate the method of rapid screening (RS) in the detection of cervical lesions and false-negative results as well as in quality control of cytotechnologist performance. MATERIAL AND METHODS The RS method was validated on Papanicolaou-stained and initially conventionally analysed vaginal, cervical and endocervical (VCE) smears collected in an opportunistic programme for the detection of cervical carcinoma. The study included 3680 VCE smears from the Department of Gynaecologic Cytology, University Department of Gynaecology and Obstetrics, Zagreb University Hospital Center, Zagreb and from the Department of Clinical Cytology, Osijek University Hospital, Osijek. Histologically verified abnormal findings accounted for 10% of the study samples. Thirteen cytotechnologists, with no previous experience in RS, performed the test. Each slide was examined using the 'step' technique for 1.5 minutes, the findings were classified as negative or abnormal, and the abnormal ones were also classified according to differential cytological diagnosis. The results were compared with those obtained on initial screening. Abnormal findings from a group of initially negative findings were reanalysed using conventional methods to make definitive cytological diagnosis. RESULTS RS yielded a sensitivity of 83.7%, specificity of 93.7%, positive predictive value of 62.4%, negative predictive value of 97.9% and diagnostic accuracy of 92.6%. Relative to the initial abnormal differential cytological diagnosis, the diagnostic value of RS increased with lesion severity [54.8%, 68.0% and 91.3% for cervical intraepithelial neoplasia (CIN) I, CIN II and CIN III respectively]. RS detected 38 additional positive findings; 94.2% of these were atypical squamous cells of undetermined significance (ASCUS)/abnormal glandular cells undetermined significance (AGUS) and CIN I. The rate of additional positive findings was 1.14% (38/3135). The false-negative rate of initial screening was 9.4% (38/406), and individual cytotechnologist sensitivity was 60.0-100.0%. CONCLUSION RS could be introduced as an efficient method of quality control to improve the sensitivity of cytological screening as well as for quality control of cytotechnologist performance.
Collapse
Affiliation(s)
- M Pajtler
- Department of Clinical Cytology, Osijek University Hospital, Osijek, Croatia.
| | | | | | | | | | | |
Collapse
|
22
|
Michelow P, McKee G, Hlongwane F. Rapid rescreening of cervical smears as a quality control method in a high-risk population. Cytopathology 2006; 17:110-5. [PMID: 16719852 DOI: 10.1111/j.1365-2303.2006.00366.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
OBJECTIVE Cancer of the cervix is one of the commonest cancers in South Africa. Accurate cytological diagnosis is one of the prerequisites for an effective cervical screening programme and requires the implementation of appropriate quality assurance modalities. This study was undertaken to determine if rapid review of reportedly negative cervical smears is a useful internal quality assurance modality in an unscreened population with very high rates of cervical carcinoma. METHOD Approximately 26% of all cervical smears received at the study institution between 1 January 1998 and 31 December 2003, and initially reported as negative or inadequate, underwent rapid review. RESULTS A total of 62,866 (26%) cervical smears out of 241,796 reportedly negative or inadequate cervical smears underwent rapid review. An amended report was sent out in 373 (0.59%) of these 62,866 cervical smears. This included 101 cases of high-grade squamous intraepithelial lesion (HSIL) and high-grade atypical squamous cells (ASC-H), 143 low-grade squamous intraepithelial lesions, 54 atypical squamous cells of undetermined significance (ASC-US) and 33 atypical glandular cells that were not reported initially. The false-negative proportion for HSIL and ASC-H (combined) in this study was 5.76%. No squamous cell carcinomas were diagnosed on rapid review but one patient with HSIL/ASC-H on review had squamous cell carcinoma on biopsy. Three cytotechnologists had a lower sensitivity of primary screening and required retraining. CONCLUSIONS Rapid review is beneficial as an internal quality assurance modality in an unscreened high-risk population and increases the detection of women with significant cervical lesions requiring treatment. The relatively low cost of rapid review compared with other rescreening modalities makes this an attractive option in low resource settings.
Collapse
Affiliation(s)
- P Michelow
- Cytology Unit, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa.
| | | | | |
Collapse
|
23
|
Collaço LM, de Noronha L, Pinheiro DL, Bleggi-Torres LF. Quality assurance in cervical screening of a high risk population: a study of 65,753 reviewed cases in Parana Screening Program, Brazil. Diagn Cytopathol 2006; 33:441-8. [PMID: 16299748 DOI: 10.1002/dc.20328] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Epidemiological data from the Quality Assurance Unit (QAU) of the Cervical Cancer Screening Program of Paraná is discussed. Slides (65,753) reviewed by the QAU, from October 1997 to July 1999, were analyzed. Relations between agreement rate, diagnostic categories, and age groups were tested. The overall agreement rate was 97.04% (kappa +/- 95%, confidence interval = 0.888 +/- 0.003). Low-grade squamous intraepithelial lesion (LSIL) showed its peak prevalence in patients < or = 19 yr (8.3%). High-grade squamous intraepithelial lesion (HSIL) was more common in women between 40 and 49 yr (5.0%). Squamous-cell carcinoma (SCC) was almost exclusively seen in women > or = 40 yr. The lowest agreement rates were seen in adenocarcinoma (54.5%; kappa = 0.667) and LSIL cases (76.3%, kappa = 0.822), and in women < or = 19 yr (95.8%). It was concluded that constant monitoring to assess specific errors allows directed measures. The 10% rescreening model of quality assurance proved to be effective in a low resources setting with a positive overall financial impact.
Collapse
|
24
|
Abstract
BACKGROUND Efficient quality control (QC) is essential to ensure high sensitivity of Papanicolaou (Pap) smears. For this purpose, rescreening of 10% random negative smears is ineffective. Rapid rescreening (RR) of all negative Pap smears is more practical and has received widespread acceptance, especially in Europe, although its sensitivity is difficult to monitor and its retrospective nature may influence the vigilance of the screeners. The method of rapid prescreening (RPS) overcomes these drawbacks because rapid review of Pap smears occurs before routine full screening. METHODS All routine conventional Pap smears over 2 months underwent RPS by 12 cytotechnologists. Approximately 30 seconds were allowed to prescreen each slide. The presence of abnormal cells (atypical squamous cells of undetermined significance [ASCUS] or above), infection or endometrial cells detected on RPS was documented. All slides subsequently underwent routine full screening. Results of both screening methods were compared. RESULTS Of a total of 8364 Pap smears, 310 (3.7%) cases were categorized as abnormal after final diagnosis. Of those, 135 were also detected on RPS (sensitivity of 43.5%). Seventeen abnormal cases were detected only on RPS: these consisted of 13 ASCUS cases, 3 low-grade squamous intraepithelial lesions, and 1 high-grade squamous intraepithelial lesion. The sensitivity of RPS for infections and endometrial cells was 51.6% and 28.3%, respectively. Implementation of RPS did not significantly impact the work flow in our laboratory. CONCLUSIONS RPS is an efficient and practical QC tool. It is a reliable method with which to monitor sensitivity and reduce the false-negative rate, and because it is done before finalizing the case, it allows for timely corrections to the diagnosis and avoids the need to amend reports.
Collapse
Affiliation(s)
- Amina Djemli
- Department of Pathology, McGill University Health Center and McGill University, Montreal, Quebec, Canada
| | | | | |
Collapse
|
25
|
Affiliation(s)
- Andrew A Renshaw
- Department of Pathology, Baptist Hospital of Miami, Miami, Florida 33176, USA.
| |
Collapse
|
26
|
Suba EJ. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries. Clin Lab Med 2004; 24:945-63. [PMID: 15555750 DOI: 10.1016/j.cll.2004.05.018] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Disease prevention requires sociopolitical change, which in turn requires the participation of those for whom the change is intended, including demographic groups at high risk for disease, appropriate governmental authorities, and essential health care personnel. Multiparous women of lowest socioeconomic status, the demographic group at highest risk for the development of cervical cancer, lack sociopolitical leverage almost by definition. Pap screening in developing countries is an idea whose time has come, but it is also an ethical imperative currently lacking a substantial sociopolitical constituency. Noncytologic screening methods currently benefit from sponsorship by corporate manufacturers and by donor organizations such as the Bill and Melinda Gates Foundation. Pap screening efforts in developing countries will benefit from the involvement of cytology organizations based in developed countries. Future assessments of the progress of cervical cancer prevention efforts in developing countries will benefit from additional examination of the interactions between quality and sociopolitical obstacles to change. Many of these obstacles will be elucidated by following the money, as well as the science, involved in cervical screening activities.
Collapse
Affiliation(s)
- Eric J Suba
- Kaiser Permanente Medical Center, 1200 El Camino Real, South San Francisco, CA 94080, USA.
| |
Collapse
|
27
|
|
28
|
Placidi A, Manca G, Mania E, Arbyn M. Rapid pre-screening of Pap smears in quality control: an Italian experience. Cytopathology 2004; 15:121-3. [PMID: 15056176 DOI: 10.1111/j.1365-2303.2004.00141.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
29
|
Saville M, Mitchell H. Randomized controlled trial evaluating rapid pre-screen of cervical cytology specimens. Cytopathology 2004; 15:12-7. [PMID: 14748786 DOI: 10.1046/j.1365-2303.2003.00111.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
A randomized controlled trial of 75,355 cervical cytology specimens was performed comparing rapid pre-screen with no pre-screen. While the percentage of cases receiving a final report of definite high-grade abnormality was higher in the no pre-screen arm (no pre-screen = 0.70%, pre-screen = 0.65%), the percentage of cases receiving a final report of possible or definite high-grade abnormality was essentially identical in the two arms of the trial (no pre-screen = 1.22%, pre-screen = 1.21%). In the randomized trial, one extra cytology report of definite high-grade abnormality was made for every 12,568 slides pre-screened. This level of benefit was reduced by about half when rapid pre-screen was adopted as a routine laboratory practice.
Collapse
Affiliation(s)
- M Saville
- Victorian Cytology Service, Carlton South, Vic., Australia.
| | | |
Collapse
|